EyePoint (EYPT) Change in Inventory (2018 - 2026)
EyePoint (EYPT) reported Change in Inventory of -$563000.0 for Q1 2026, down 219.89% on a YoY basis from $469611.4 in Q1 2025, and down 89.56% sequentially from -$297000.0 in Q4 2025.
EyePoint (EYPT) Change in Inventory (2018 - 2026) Analysis & Trends
EyePoint (EYPT) has 9 years of Change in Inventory data on file, last reported at -$563000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 219.89% year-over-year to -$563000.0; the trailing twelve-month figure through Mar 2026 stood at -$879000.0 (up 58.67% YoY), and the FY2025 full-year result was -$492000.0, up 69.25% from the prior year.
- Change in Inventory retreated to -$563000.0 in Q1 2026, from -$297000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.2 million in Q1 2023 to a low of -$865000.0 in Q3 2024.
- A 5-year average of -$20117.6 and a median of -$176000.0 in 2025 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory surged 982.93% in 2023 and plunged 374.6% in 2024, its largest moves.
- Tracing EYPT's Change in Inventory over 5 years: stood at $845000.0 in 2022, then sank by 179.41% to -$671000.0 in 2023, then rose by 25.19% to -$502000.0 in 2024, then jumped by 40.84% to -$297000.0 in 2025, then sank by 89.56% to -$563000.0 in 2026.
- Business Quant data shows EYPT's Change in Inventory at -$563000.0 in Q1 2026, -$297000.0 in Q4 2025, and -$568000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -563,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -563,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | -176,000.00 |
| Mar 31, 2025 | -176,000.00 |
| Dec 31, 2024 | -502,000.00 |
| Dec 31, 2024 | -502,000.00 |
| Sep 30, 2024 | -865,000.00 |
| Sep 30, 2024 | -865,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | -671,000.00 |
| Dec 31, 2023 | -671,000.00 |